ACET - Adicet Bio, Inc. News

Adicet Bio Reveals FDA Clearance Of IND Application For ADI-212; Co Plans To Initiate Phase 1 Enroll

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing al

Adicet Bio Announces FDA Clearance of IND Application for ADI-212

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Here's Why You Should Add ACET Stock to Your Portfolio Now

Adicet Bio advances prula-cel in autoimmune diseases while pursuing new opportunities in prostate ca

Are Medical Stocks Lagging Adicet Bio (ACET) This Year?

Here is how Adicet Bio, Inc. (ACET) and Agilent Technologies (A) have performed compared to their se

seekingalpha.com

Adicet Bio: A Cheap Gamma Delta T-Cell Play

Adicet Bio offers a differentiated allogeneic gamma delta CAR-T platform targeting autoimmune diseas

Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet

The consensus price target hints at a 301.6% upside potential for Adicet Bio (ACET). While empirical

marketbeat.com

Adicet Bio Eyes Key Lupus Data This Quarter for Off-the-Shelf Cell Therapy

Adicet Bio NASDAQ: ACET expects to report clinical data this quarter for its lead autoimmune program

All You Need to Know About Adicet Bio (ACET) Rating Upgrade to Buy

Adicet Bio (ACET) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $90

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the pric

Adicet Bio Q2 EPS $(1.99) Beats $(2.03) Estimate

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(1.99) per share which beat the analyst conse

Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

prnewswire.com

Lipocine Appoints Michael J. Grissinger to Board of Directors

/PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary

Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Is Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their secto

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m

10 Health Care Stocks Moving In Monday's Pre-Market Session

marketbeat.com

Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference

Adicet Bio NASDAQ: ACET outlined its near-term clinical priorities and upcoming data catalysts durin

Are Medical Stocks Lagging Adicet Bio (ACET) This Year?

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their secto

Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 319.6% in A

Adicet Bio Q1 EPS $(1.88) Beats $(3.21) Estimate

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(1.88) per share which beat the analyst conse

Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

Adicet Bio (ACET) Upgraded to Buy: Here's Why

Adicet Bio (ACET) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the

HC Wainwright & Co. Maintains Buy on Adicet Bio, Lowers Price Target to $27

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and lo

Guggenheim Maintains Buy on Adicet Bio, Lowers Price Target to $100

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and lowers the pric

Adicet Bio Q4 EPS $(2.94) Beats $(3.10) Estimate

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(2.94) per share which beat the analyst conse

Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

defenseworld.net

Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) PT at $69.00

Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) has been assigned a consensus recommendation of "M

defenseworld.net

Adicet Bio, Inc. (NASDAQ:ACET) Receives $69.00 Consensus PT from Brokerages

Shares of Adicet Bio, Inc. (NASDAQ: ACET - Get Free Report) have received a consensus rating of "Mod

Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnolo

HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $50

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and ra

Adicet Bio Extends Cash To 2027 As Enrollment Doubles For Lead Autoimmune Drug

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing al

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalim

What's Going On With Adicet Bio Stock Today?

Shares of Adicet Bio are trading lower after the clinical stage biotechnology company announced a on

HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $9

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and ra

12 Health Care Stocks Moving In Tuesday's After-Market Session

Guggenheim Maintains Buy on Adicet Bio, Raises Price Target to $8

Guggenheim analyst Yatin Suneja maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the pric

Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2

Adicet Bio reported strong Phase 1 lupus trial results with ADI-001, showing 100% response in nephri

Adicet Bio Shares Initial Safety And Efficacy Data From The First Seven Patients Dosed With ADI-001

Clinical data to date supports a potentially transformational approach to treating autoimmune diseas

Guggenheim Reiterates Buy on Adicet Bio, Maintains $7 Price Target

Guggenheim analyst Yatin Suneja reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $7 p

12 Health Care Stocks Moving In Tuesday's After-Market Session

Adicet Bio Q2 EPS $(0.34) Misses $(0.30) Estimate

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.34) per share which missed the analyst con

HC Wainwright & Co. Assumes Adicet Bio at Buy, Announces Price Target of $4

HC Wainwright & Co. analyst Robert Burns assumes Adicet Bio (NASDAQ:ACET) with a Buy rating a

Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Adicet Bio Q1 EPS $(0.31) Beats $(0.34) Estimate

Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.31) per share which beat the analyst conse

12 Health Care Stocks Moving In Thursday's After-Market Session

Guggenheim Reiterates Buy on Adicet Bio, Maintains $7 Price Target

Guggenheim analyst Yatin Suneja reiterates Adicet Bio (NASDAQ:ACET) with a Buy and maintains $7 p

Citizens Capital Markets Reiterates Market Perform on Adicet Bioto Market Perform

Citizens Capital Markets analyst Reni Benjamin reiterates Adicet Bio (NASDAQ:ACET) from Market Pe